FGP
MEDP icon

Freestone Grove Partners’s Medpace MEDP Stock Holding History

Freestone Grove Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,908
Closed -$10.2M – 850
2025
Q3 		$10.2M Buy
+19,908
New +$8.69M 0.08% 284

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Freestone Grove Partners's MEDP Position: Q4 2025 in Review

Freestone Grove Partners sold out of Medpace (MEDP) in Q4 2025, closing a stake of 19,908 shares — an estimated $10.2M sold.

Freestone Grove Partners first reported a position in MEDP in Q3 2025 and held it in 1 quarter. The position peaked at $10.2M in Q3 2025. 785 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

  • Freestone Grove Partners reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 19,908 Medpace shares in Q4 2025, an estimated $10.2M.
  • Freestone Grove Partners first reported a position in Medpace in Q3 2025 and held it in 1 quarter.
  • Freestone Grove Partners's Medpace position peaked at $10.2M in Q3 2025.
  • 785 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Freestone Grove Partners's 13F filing for Q4 2025, filed 17 Feb 2026.